中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
35期
42-43,44
,共3页
钟宝元%谢军%叶建明%刘瑶
鐘寶元%謝軍%葉建明%劉瑤
종보원%사군%협건명%류요
金属支架%左半结肠癌%梗阻
金屬支架%左半結腸癌%梗阻
금속지가%좌반결장암%경조
Metallic stent%Left colon cancer%Obstruction
目的:探讨金属支架在左半结肠癌合并梗阻中的临床应用价值。方法:选取20例左半结肠癌合并梗阻患者,均行金属支架置入梗阻后一期切除吻合,探讨其临床疗效。结果:20例患者金属支架置入梗阻后2 d腹围减少至置入前的(86.2±3.0)%,差异具有统计学意义(P<0.01);腹部立位X线片示液气平减少,肠管扩张程度减轻,近端结肠最大横径减少至(4.32±0.6)cm,与置入前的(8.1±0.7)cm比较,差异具有统计学意义(P<0.01);患者腹痛、腹胀症状较术前均明显缓解。结论:结肠金属支架应用于左半结肠癌并梗阻患者行一期肠切除吻合,是安全、有效的治疗方法,值得推广。
目的:探討金屬支架在左半結腸癌閤併梗阻中的臨床應用價值。方法:選取20例左半結腸癌閤併梗阻患者,均行金屬支架置入梗阻後一期切除吻閤,探討其臨床療效。結果:20例患者金屬支架置入梗阻後2 d腹圍減少至置入前的(86.2±3.0)%,差異具有統計學意義(P<0.01);腹部立位X線片示液氣平減少,腸管擴張程度減輕,近耑結腸最大橫徑減少至(4.32±0.6)cm,與置入前的(8.1±0.7)cm比較,差異具有統計學意義(P<0.01);患者腹痛、腹脹癥狀較術前均明顯緩解。結論:結腸金屬支架應用于左半結腸癌併梗阻患者行一期腸切除吻閤,是安全、有效的治療方法,值得推廣。
목적:탐토금속지가재좌반결장암합병경조중적림상응용개치。방법:선취20례좌반결장암합병경조환자,균행금속지가치입경조후일기절제문합,탐토기림상료효。결과:20례환자금속지가치입경조후2 d복위감소지치입전적(86.2±3.0)%,차이구유통계학의의(P<0.01);복부립위X선편시액기평감소,장관확장정도감경,근단결장최대횡경감소지(4.32±0.6)cm,여치입전적(8.1±0.7)cm비교,차이구유통계학의의(P<0.01);환자복통、복창증상교술전균명현완해。결론:결장금속지가응용우좌반결장암병경조환자행일기장절제문합,시안전、유효적치료방법,치득추엄。
Objective:To explore the clinical value of metallic stent in the treatment of left colon malignant obstruction. Method:Select 20 cases of left colon cancer with obstruction of patients,all line metal stent obstruction after a resection and anastomosis,to explore the clinical curative effect. Result:20 patients metal stent obstruction before 6 to 2 days after placement(86.2±3.0)%,statistically significant difference(P<0.01).Abdominal stand X-ray film in liquid gas flat cut,reduce blind expansion degree and proximal colonic maximum transverse diameter down to(4.32±0.6)cm, prior to the placement of(8.1±0.7)cm,statistically significant difference(P<0.01).Patients with abdominal pain and abdominal distension symptoms were obviously relieved. Conclusion:Left colon malignant obstruction can be relieved effectively by metallic stent. Metallic stent can provide safe and effective treatment for the colon cancer patients,and create the condition for tumor resection,the method worth promoting.